Administration of AS03B-adjuvanted A(H1N1)pdm09 Vaccine in Children Aged <3 Years Enhances Antibody Response to H3 and B Viruses Following a Single Dose of Trivalent Vaccine One Year Later

被引：9
作者：
Hoschler, Katja [1 ]
Andrews, Nick J. [1 ]
Faust, Saul N. [2 ]
Finn, Adam [3 ]
Pollard, Andrew J. [4 ]
Snape, Matthew D. [4 ]
Walker, Woolf T. [2 ]
Zambon, Maria [1 ]
Miller, Elizabeth [1 ]
机构：
[1] Publ Hlth England Colindale, London, England
[2] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England
[3] Univ Bristol, Bristol BS8 1TH, Avon, England
[4] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX1 2JD, England
来源：
CLINICAL INFECTIOUS DISEASES | 2014年 / 58卷 / 02期
关键词：
vaccine; influenza; childhood; oil-in-water adjuvant; cross-reactive effects; INACTIVATED INFLUENZA VACCINE; PANDEMIC VACCINE; SPLIT-VIRION; OPEN-LABEL; IMMUNOGENICITY; SAFETY; REACTOGENICITY; MULTICENTER; PERSISTENCE; EMULSION;
D O I：
10.1093/cid/cit692
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background. We report on a follow-up clinical and serological investigation of 274 children who received seasonal influenza vaccine (trivalent inactivated vaccine [TIV]) 1 year after receipt of either AS03(B)-adjuvanted subunit or whole virus monovalent A(H1N1)pdm09 vaccine and describe the antibody responses to the H3N2 A/Perth/16/2009 and B/Brisbane/60/2008 components of TIV. Methods. Vaccine responses were analyzed using hemagglutination inhibition (HAI) assays. In children aged <3 years, previous receipt of adjuvanted vaccine resulted in higher HAI antibody responses to H3N2 and B strains compared with nonadjuvanted vaccine (fold change 16.8 vs 4.3 for H3N2 and 7.0 vs 1.6 for B). In children aged >3 years, responses to the H3 and B components of TIV were similar between vaccine groups. Sera taken before and after the pandemic vaccine were also analyzed by HAI using A/Perth/16/2009 virus. This analysis showed that 11.1% of children receiving the AS03(B)-adjuvanted vaccine but only 1.4% in the nonadjuvanted group had a 4-fold rise to A/Perth/16/2009. Conclusion. AS03(B)-adjuvanted A(H1N1)pdm09 influenza vaccine generates a cross-reactive antibody response to H3N2 in children and enhances responses to heterologous subtypes in children aged <3 years 1 year later.
引用
收藏
页码：181 / 187
页数：7
相关论文
共 22 条
[1]   Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines [J].
Andrews, Nick J. ;
Walker, Woolf T. ;
Finn, Adam ;
Heath, Paul T. ;
Collinson, Andrew C. ;
Pollard, Andrew J. ;
Snape, Matthew D. ;
Faust, Saul N. ;
Waight, Pauline A. ;
Hoschler, Katja ;
Sheasby, Liz ;
Waddington, Claire ;
Kerridge, Simon ;
Chalk, Jeremy ;
Reiner, Amanda ;
John, Tessa ;
Fletcher, Margaret ;
Allen, Ruth ;
Fineman, Natalie ;
Wilkins, Su ;
Casey, Michelle ;
Michaelis, Louise ;
Oeser, Clarissa ;
Okike, Ifeanyichukwu ;
Ladhani, Shamez ;
Miller, Elizabeth .
VACCINE, 2011, 29 (45) :7913-7919
[2]   Assessment of Antigen-Specific and Cross-Reactive Antibody Responses to an MF59-Adjuvanted A/H5N1 Prepandemic Influenza Vaccine in Adult and Elderly Subjects [J].
Bihari, Ivan ;
Panczel, Gyula ;
Kovacs, Jozsef ;
Beygo, Jenny ;
Fragapane, Elena .
CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (12) :1943-1948
[3]   Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes [J].
Calabro, Samuele ;
Tortoli, Marco ;
Baudner, Barbara C. ;
Pacitto, Alessandra ;
Cortese, Mario ;
O'Hagan, Derek T. ;
De Gregorio, Ennio ;
Seubert, Anja ;
Wack, Andreas .
VACCINE, 2011, 29 (09) :1812-1823
[4]  
de Whalley P, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI [10.3310/hta15450, 10.3310/hta15suppl1/02]
[5]  
Department of Health, IMMUNISATION INFECT
[6]   Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years A Phase II, Randomized, Open, Controlled Study [J].
Diez-Domingo, Javier ;
Garces-Sanchez, Maria ;
Baldo, Jose-Maria ;
Victoria Planelles, Maria ;
Ubeda, Isabel ;
JuBert, Angels ;
Mares, Josep ;
Moris, Philippe ;
Garcia-Corbeira, Pilar ;
Drame, Mamadou ;
Gillard, Paul .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (06) :E35-E46
[7]   One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies [J].
Faenzi, Elisa ;
Zedda, Luisanna ;
Bardelli, Monia ;
Spensieri, Fabiana ;
Borgogni, Erica ;
Volpini, Gianfranco ;
Buricchi, Francesca ;
Pasini, Franco Laghi ;
Capecchi, Pier Leopoldo ;
Montanaro, Fabio ;
Belli, Riccardo ;
Lattanzi, Maria ;
Piccirella, Simona ;
Montomoli, Emanuele ;
Ahmed, Syed Sohail ;
Rappuoli, Rino ;
Del Giudice, Giuseppe ;
Finco, Oretta ;
Castellino, Flora ;
Galli, Grazia .
VACCINE, 2012, 30 (27) :4086-4094
[8]  
Garçon N, 2012, EXPERT REV VACCINES, V11, P349, DOI [10.1586/erv.11.192, 10.1586/ERV.11.192]
[9]   Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children [J].
Gilca, Vladimir ;
De Serres, Gaston ;
Hamelin, Marie-Eve ;
Boivin, Guy ;
Ouakki, Manale ;
Boulianne, Nicole ;
Sauvageau, Chantal ;
Dionne, Marc ;
Gilca, Rodica ;
Skowronski, Danuta .
VACCINE, 2011, 30 (01) :35-41
[10]   Original Antigenic Sin Responses to Influenza Viruses [J].
Kim, Jin Hyang ;
Skountzou, Ioanna ;
Compans, Richard ;
Jacob, Joshy .
JOURNAL OF IMMUNOLOGY, 2009, 183 (05) :3294-3301
123